MSH|^~\&|NIST Test Lab APP|NIST Lab Facility||NIST EHR Facility|20110531140551-0500||ORU^R01^ORU_R01|LRI_5.4_1.1-NG_FRU|D|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_NG_Component^^2.16.840.1.113883.9.13^ISO~LAB_FRU_Component^^2.16.840.1.113883.9.83^ISOPID|1||PATID1239^^^NIST MPI^MR||Smirnoff^Peggy^^^^^L||19750401|F||2106-3^White^HL70005^wh^white^L||||||||PATID1239^^^NIST MPI^MRORC|RE|ORD448811^NIST EHR|R-511^NIST Lab Filler|||||||||5742200012^Radon^Nicholas^^^DR^^^NPI^L^^^NPIOBR|1|ORD448811^NIST EHR|R-511^NIST Lab Filler|HepABC Panel^Hepatitis A B C Panel^L|||20120628070100|||||||||5742200012^Radon^Nicholas^^^DR^^^NPI^L^^^NPI||||||20110331160428-0800|||COBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Quant^L||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<0.50 IU/mL|N|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004^Positive (qualifier value)^SCT^POS^POSITIVE^L^^^Positive (qualifier value)||Negative|A|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTOBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H|||F|||20120628070100|||||20120628100500||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLTNTE|1||Negative:   < 0.8 \E\.br\E\ Indeterminate 0.8 - 0.9 \E\.br\E\ Positive:  > 0.9 \E\.br\E\ In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confirmed with additional Verification or PCR testing.SPM|1|S2015-777888&NIST EHR^S-220713-1&NIST Lab Filler||119297000^BLD^SCT^^^^^^Blood|||||||||||||20110531123551-0800ORC|RE||R-512^NIST Lab Filler|||||||||5742200012^Radon^Nicholas^^^DR^^^NPI^L^^^NPIOBR|2||R-512^NIST Lab Filler|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L|||20120628070100||||G|||||5742200012^Radon^Nicholas^^^DR^^^NPI^L^^^NPI||||||20110331160428-0800|||C|16128-1&Hepatitis C virus Ab [Presence] in Serum&LN&HCVAB&Hepatitis C antibody screen  (anti-HCV)&L|||ORD448811&NIST EHR^R-511&NIST Lab FillerOBX|1|SN|11011-4^Hepatitis C virus RNA [Units/â€‹volume] (viral load) in Serum or Plasma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|<43 IU/mL|H|||F|||20120628070100|||||20120629092700||||Century Hospital^^^^^CLIA^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT